Genprex Logo large
Genprex Logo icon format
About Genprex
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.
- Website domain: genprex.com
- Employees: 17
- Marketcap: $46.77 Million USD
November 22nd, 2020
